TAKEAWAY: The FINGER and U.S. POINTER randomized clinical trials enrolled overlapping but distinct cohorts. Analyzing the subsets of participants who likely meet eligibility criteria for both trials and those who do not replicates findings among intersecting individuals and extends benefits to non-overlapping cohorts.